PART I . Overview Aspire is an early-stage biopharmaceutical company. As a Delaware corporation formed in February 2025, the Company engages in the business of developing and marketing the disruptive technology for novel sublingual delivery mechanisms initially for known drugs. Prior to our Business Combination we were a privately held Puerto Rico corporation incorporated in September 2021. Our internet address is www.aspirebiolabs.com. Business Plan We expect to generate revenue through develop...
Q2 FY2026 — expected 2026-09-25
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-03-30 | 2025-12-31 | 0001493152-26-013682 | EDGAR | 89K words |
| 2025-04-07 | 2024-12-31 | 0001641172-25-002917 | EDGAR | — |
| 2024-03-11 | 2023-12-31 | 0001493152-24-009602 | EDGAR | — |
| 2023-03-21 | 2022-12-31 | 0001410578-23-000316 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2025-11-14 | 2025-09-30 | 0001493152-25-022595 | EDGAR | 34K words |
| 2025-08-13 | 2025-06-30 | 0001641172-25-023573 | EDGAR | — |
| 2025-05-14 | 2025-03-31 | 0001641172-25-010316 | EDGAR | — |
| 2024-11-14 | 2024-09-30 | 0001493152-24-045850 | EDGAR | — |
| 2024-08-16 | 2024-06-30 | 0001493152-24-032815 | EDGAR | — |
| 2024-06-05 | 2024-03-31 | 0001493152-24-022728 | EDGAR | — |
| 2023-11-08 | 2023-09-30 | 0001493152-23-039795 | EDGAR | — |
| 2023-08-08 | 2023-06-30 | 0001410578-23-001594 | EDGAR | — |
| 2023-05-11 | 2023-03-31 | 0001410578-23-001031 | EDGAR | — |
| 2022-11-10 | 2022-09-30 | 0001410578-22-003172 | EDGAR | — |
| 2022-08-11 | 2022-06-30 | 0001410578-22-002287 | EDGAR | — |
| 2022-05-16 | 2022-03-31 | 0001410578-22-001691 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-02-12 | 0001493152-26-006343 | EDGAR | 25K words |
| 2026-02-06 | 0001493152-26-005640 | EDGAR | — |
| 2026-01-30 | 0001493152-26-004543 | EDGAR | — |
| 2026-01-15 | 0001493152-26-002326 | EDGAR | — |
| 2026-01-13 | 0001493152-26-002057 | EDGAR | — |
| 2026-01-06 | 0001493152-26-000518 | EDGAR | — |
| 2025-11-14 | 0001493152-25-022580 | EDGAR | — |
| 2025-11-05 | 0001493152-25-020891 | EDGAR | — |
| 2025-10-17 | 0001493152-25-018512 | EDGAR | — |
| 2025-09-26 | 0001493152-25-015773 | EDGAR | — |
77 total filings indexed. 51 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001847345 |
| Ticker | ASBP |
| Exchange | Nasdaq |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | E9 |
| Website | https://www.aspirebiolabs.com |
| Listed | 2025-02-20 |
This is the free public profile. For structured JSON with full provenance chain, use the API:
JSON Profile Stock Quote AI Readiness Report